Probiotic developer Synbiotic Health acquires new facility in Madison, Wisconsin
The facility is expected to be operational in early 2023.
Probiotic developer Synbiotic Health (Lincoln, NE) has acquired a new facility in Madison, WI. The 43,000-sq-ft facility is expected to be operational in early 2023 and will focus on “scale-up and development of efficient commercial processes.”
The company’s existing facilities in Lincoln, NE, focus on discovering new probiotic strains. The new Madison facility “is being constructed specifically to support probiotics in a quality-focused GMP environment that features very low humidity levels in all areas where probiotic ingredients will be found,” the company says in a press release. “New lab space, which will have the capacity to accommodate numerous scientists, will allow Synbiotic Health to quickly screen new probiotics for growth and stability, thus increasing the company’s ability to introduce new, high-quality strains to the market.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
